Devices › Device types
FDA product code OGO · class 3 · Unknown
Intraocular pressure lowering implant: medical device reports filed with FDA
2,684 reports carry this product code, 2007–2026; 6 brands with a page.
- 2,684
- reports with this product code
- 0% of all MAUDE reports
- 180
- reports, 12 months to August 2026
- 151 in the 12 months before
- 24.9%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code OGO is FDA's classification for "Intraocular pressure lowering implant" (unknown panel), a class 3 device. 2,684 medical device reports carry this product code, 0% of the MAUDE database, from May 2007 to August 2026.
180 reports arrived in the 12 months to August 2026, up 19% from 151 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (75.1%) and malfunction (24.9%). 6 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Cypass System | 821 | 6 | 0% | 13% |
| Istent Trabecular Micro-Bypass | 521 | 0 | 0% | 18.5% |
| Hydrus Microstent | 476 | 115 | 0% | 19.3% |
| Istent Inject W Trabecular Micro Bypass System | 366 | 0 | 0% | 60.1% |
| Istent Inject Trabecular Micro Bypass System | 213 | 0 | 0% | 26.3% |
| iStent Infinite Trabecular Micro-Bypass System | 2 | 65 | 0% | 30% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Glaukos | 1,333 | 49.7% |
| Alcon Research - Alcon Precision Device | 120 | 4.5% |
| Staar Surgical | 5 | 0.2% |
| Alcon Laboratories | 2 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Malposition of device | 413 | 15.4% |
| Insufficient device problem information | 202 | 7.5% |
| Obstruction of flow | 177 | 6.6% |
| Breakthe device broke | 136 | 5.1% |
| Device dislodged or dislocated | 88 | 3.3% |
| Patient-device incompatibilitythe device did not suit the patient | 49 | 1.8% |
| Difficult to advance | 42 | 1.6% |
| Device operates differently than expectedthe device behaved unexpectedly | 37 | 1.4% |
| Migrationthe device moved from where it was placed | 37 | 1.4% |
| Migration or expulsion of device | 37 | 1.4% |
| Separation failure | 30 | 1.1% |
| Improper or incorrect procedure or method | 29 | 1.1% |
| Positioning problem | 28 | 1% |
| Contamination | 21 | 0.8% |
| Defective devicethe device was defective | 13 | 0.5% |
| Activation, positioning or separation problem | 10 | 0.4% |
| Unexpected therapeutic results | 10 | 0.4% |
| Difficult to insertthe device was hard to insert | 8 | 0.3% |
| Therapeutic or diagnostic output failure | 8 | 0.3% |
| Device stenosis | 7 | 0.3% |
Questions about intraocular pressure lowering implant reports
What is product code OGO?
FDA's classification code for "Intraocular pressure lowering implant", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
2,684 reports through August 2026, 180 of them in the latest 12 months.
Which brands appear most often?
Cypass System (821), Istent Trabecular Micro-Bypass (521), Hydrus Microstent (476), Istent Inject W Trabecular Micro Bypass System (366) and Istent Inject Trabecular Micro Bypass System (213). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.